Mobina Nakhaei: Why Alloantibodies Develop Despite ABO/Rh Matching in Thalassemia
Mobina Nakhaei, Researcher in Hematology and Transfusion Medicine and Member of the Educational Development Center at Tarbiat Modares University, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in Annals of Hematology, adding:
“Why Do Thalassemia Patients Still Develop Alloantibodies Despite ABO/Rh Matching?
A question we addressed in our study on transfusion‑dependent β‑thalassemia patients in Eastern Iran.
Our findings, published in Annals of Hematology (Springer), highlight the ongoing challenge of red blood cell alloimmunization – even with standard ABO and Rh matching.
What we found:
- 74 patients (50% male, 50% female) from South Khorasan
- Alloimmunization prevalence: 9.5%
- 16 alloantibodies identified
- Most common: anti‑K (43.75%) and anti‑E (43.75%)
- Followed by anti‑C (12.5%)
- Blood group O was the most frequent phenotype (39.2%)
- Rh antigens c and e: present in 94.6%
- No significant association with age, sex, blood group, or splenectomy
The takeaway:
To improve transfusion safety, we need to go beyond ABO/Rh – extended matching for Kell and Rh systems, combined with regular antibody screening, is essential in high‑risk populations.
Grateful to my supervisor Fatemeh Mezginejad and my colleague for their collaboration on this work.”
Title: Red blood cell alloimmunization in transfusion-dependent β-thalassemia major patients in Eastern Iran
Authors: Mobina Nakhaei Shamahmood, Mohammad Reza Meghdadi, Maziar Nasiri, Mohammad Javad Yousefi, Fatemeh Mezginejad

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 17, 2026, 10:41Elena Petkovic։ Highlights from the ISBT–WHO Plasma Management Workshop
-
Nov 17, 2026, 10:30Cheng-Hock Toh: Haematology Is Everywhere – But Is It Recognised?
-
Nov 17, 2026, 10:23Akshat Jain: The Importance of Knowing Your Sickle Cell Status
-
Nov 17, 2026, 10:12Caitlin Raymond: What Does Apheresis Really Cost?
-
Nov 17, 2026, 05:47Multidisciplinary Teams Kick Off SAHF MASAC ES 2026 with Pre-Symposium Workshops – South African Haemophilia Foundation
-
Nov 17, 2026, 05:41Boitumelo Malatji: South African Delegation Advances Advocacy Strategies at NNHF Southern Africa Workshop
-
Nov 17, 2026, 05:36Joining the PACTA Uganda Mental Health and Addiction Community Camp 2026 – Tackle Sickle Cell Africa
-
Nov 17, 2026, 05:30Nathan Connell: Women’s Hematology Summit 2027 to Address Hematologic Health Across the Lifespan
-
Nov 17, 2026, 05:25Mane Kurghinyan: Representing Armenia and HemAI Dynamics at the Falling Walls Lab Global Finale 2026